This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Effects of Omega 3 in Hemodialysis Patients

This study has been completed.
Information provided by:
Laboratoire Régional de Nutrition Humaine Identifier:
First received: February 3, 2007
Last updated: March 2, 2016
Last verified: February 2007
The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.

Condition Intervention
Hemodialysis End Stage Renal Disease Behavioral: fish oil supplementation

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Screening
Official Title: Effets of Fish Oil on Metabolic Fate of an Oral Glucose Load in Patients With End Stage Renal Disease Undergoing Hemodialysis

Resource links provided by NLM:

Further study details as provided by Laboratoire Régional de Nutrition Humaine:

Primary Outcome Measures:
  • plasma glucose utilization
  • glucose-induced thermogenesis

Estimated Enrollment: 8
Study Start Date: May 2003
Estimated Study Completion Date: November 2003

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • hemodialysis at least 6 months duration end stage renal disease

Exclusion Criteria:

  • - Age < 18 y ou > 75 y
  • Hemodialysis < 6 months
  • Diabetes, obesity
  • allergy to fish
  • Asthma
  • glucocorticoïds, propranolol,, Immunosuppressive drugs, Insulin, Somatostatin
  • erythropoïetin < 3 months
  • Cancer
  • Hemoglobin < 11 g/l
  • disease < 1 month
  • pregnancy
  • respiratory insufficiency
  • intensive sport practice
  • refusal
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00431899

Laboratoire Régional de Nutrition Humaine
Brest, France, F-29200
Sponsors and Collaborators
Laboratoire Régional de Nutrition Humaine
Principal Investigator: Jacques Delarue, MD,PhD CHU Cavale Blanche F-29200 Brest
  More Information Identifier: NCT00431899     History of Changes
Other Study ID Numbers: HDW3
Study First Received: February 3, 2007
Last Updated: March 2, 2016

Keywords provided by Laboratoire Régional de Nutrition Humaine:
omega 3 fatty acids
insulin resistance

Additional relevant MeSH terms:
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
Urologic Diseases
Renal Insufficiency processed this record on June 23, 2017